A communication resource from the world's particle physics laboratories.
Many laboratories around the world, including Interactions members, are involved in the battle against the novel coronavirus, COVID-19. We will maintain this page with updated news about their efforts.
Officials at the Cook County Sheriff's office are hoping the sewers at the jail could lead to groundbreaking new clues in their battle against the deadly virus
COVID-19 research at Argonne continues at the laboratory’s Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility, to precisely determine the structures of the 28 unique proteins that make up the SARS-CoV-2 virus, which causes COVID-19. As these structures are determined, they are posted into an international Protein Data Bank (PDB), compiled by researchers around the world.
Argonne is bringing the power of its scientific leadership and state-of-the-art user facilities to bear in the global battle against COVID-19.
Scientists discover critical protein that lets virus hide from immune system.
COVID-19 needs no introduction. Scientists fighting it do.
Interns contributed to aerosol modeling research to better understand airborne virus
NY State-funded cryo-electron microscopes at Brookhaven Lab's Laboratory for BioMolecular Structure are now open for COVID-19-related research
As of April 27, Fermilab has contributed a total of 1.8 million core hours to the pandemic-fighting effort carried out by projects such as Folding@home, which is simulating how viral proteins fold to help scientists design better therapeutics.
Deep learning paired with drug docking and molecular dynamics simulations identify small molecules to shut down virus
Project will sift through 1 billion drug-like molecules and 60 sites on virus to find most promising options for targeted drug development
Brookhaven Lab scientists and staff combine expertise across disciplines and use Lab’s unique facilities to address drug development, medical supplies, information processing, and more
CERN and LHC computing sites are supporting the Folding@home volunteer-computing initiative
Zenodo and OpenAIRE are contributing to the European Commission call for action with what they do best – preserving and sharing all COVID-19-related datasets, software, preprints and other research objects
A team led by physicists from the LHCb collaboration has developed a design for a novel ventilator to help patients with severe COVID-19 symptoms.
As part of the CERN against COVID-19 initiative, CERN has produced and delivered personal protective equipment to local organisations in the front line.
The “CERN against COVID-19” taskforce, which coordinates the actions, has received hundreds of suggestions to contribute to the efforts to curb the pandemic
CERN establishes a task force to identify and support contributions from the Organization to combatting COVID-19 pandemic
Screening could greatly accelerate the search for a drug
More than 3,500 researchers from around the world collaborate with the U.S. Department of Energy’s Fermi National Accelerator Laboratory to develop state-of-the-art technologies and solve the mysteries of matter, energy, space and time.
As with all first responders across the nation, the Fermilab Fire Department stands ready to act should they be called upon to help with a COVID-19 incident in the areas surrounding the suburban Illinois laboratory.
It was mid-March, and physicist Cristiano Galbiati was not where he expected to be. The professor at both Princeton University and Gran Sasso Science Institute was meant to be in Sardinia, thinking about the cryogenic distillation column he was building for the DarkSide-20k dark matter experiment.
In a little over a month, a team of physicists and engineers from around the world took a simplified ventilator design from concept all the way through approval by the U.S. Food and Drug Administration. This major milestone marks the ventilator as safe for use in the United States under the FDA’s Emergency Use Authorization, which helps support public health during a crisis.
In a little over a month, a team of physicists and engineers from around the world took a simplified ventilator design from concept all the way through approval by the U.S. Food and Drug Administration. This major milestone marks the ventilator as safe for use in the United States under the FDA’s Emergency Use Authorization, which helps support public health during a crisis.
As of April 27, Fermilab has contributed a total of 1.8 million core hours to the pandemic-fighting effort carried out by projects such as Folding@home, which is simulating how viral proteins fold to help scientists design better therapeutics.
The IN2P3 makes every effort to ensure the continuity of administrative and research activities.
The National Institute of Nuclear Physics in Rome, (or INFN - Istituto Nazionale di Fisica Nucleare) has been working diligently to combat the spread of the novel coronavirus, COVID-19.
See their concerted efforts, from computer simulation to ventilator fabrication, on the INFN COVID-19 Projects page.
Joint press release Sibylla Biotech-INFN: New binding pockets of the ACE2 protein found for subsequent pharmacological studies, and 35 promising molecules selected from the computer among the 9000 analyzed, including one molecule of the chemical family of hydroxychloroquine. The next step is to go to the laboratory.
The Anti-Covid Lab "has been developed by the University of Catania and by the National Laboratories of the South (LNS) of the National Institute of Nuclear Physics for the verification of the functional qualities of fabrics intended for the realization of masks and others PPE for the prevention of contagion in the COVID-19 emergency.
Stop the virus before it can penetrate cells by neutralizing your Trojan horse. This is the challenge launched at COVID-19 by Sibylla Biotech, a spin-off of the National Institute of Nuclear Physics (INFN) and of the Universities of Trento and Perugia, which is working on the identification of an anti COVID-19 therapy with a technology unique that studies the behavior of proteins in a completely new way and quickly.
The U.S. Department of Energy’s (DOE’s) Lawrence Berkeley National Laboratory (Berkeley Lab) is part of a multi-laboratory working group that recently received DOE Office of Science funding under the Coronavirus Aid, Relief, and Economic Security (CARES) Act to conduct R&D to help improve the nation’s COVID-19 testing capabilities.
Scientists around the world are joining together to study the coronavirus known as SARS-CoV-2 and to expedite the development of possible vaccines and treatments to prevent its infectious disease, named COVID-19. At the U.S. Department of Energy’s (DOE’s) Lawrence Berkeley National Laboratory (Berkeley Lab), some unique capabilities and facilities are being called into action quickly to assist in the national COVID-19 response.
Starting this month the SURF Open Innovation Lab (SOIL) has introduced a new experimental graphical computing cluster that is accessible to all Dutch scientists. The cluster is unique in the Netherlands and is located at Nikhef in Amsterdam.
Nikhef is dedicating their new and freshly installed computer cluster – which is still in its test phase – to the calculation efforts in order to fight the coronavirus. The datacentre is offering their computing power to the Rosetta@home project of the University of Washington, that tries to unravel the underlying protein structure with massive calculation nodes.
Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2.
Two biotech start-ups at Daresbury Laboratory have developed a new type of COVID-19 testing platform that is rapid, low cost and easy to use.
A new UK study will seek to understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions, including cancer.
Local businesses supported by Innovate UK are getting the east and south-east of England ready to build back better after coronavirus.
COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study.
UK Research and Innovation (UKRI) has announced further action to support PhD students whose studies are being affected by COVID-19.
A national consortium will bring together modellers to produce rigorous predictions for the COVID-19 pandemic to advise UK government bodies.
UK Research and Innovation (UKRI) is supporting seven projects with a £31 million investment to demonstrate how quantum technologies could solve some of the greatest mysteries in fundamental physics.
Just as quantum computing promises to revolutionise traditional computing, technologies such as quantum sensors have the potential to radically change our approach to understanding our universe.
CERN’s High Luminosity LHC project (HL-LHC), a large international collaboration, will deliver cutting-edge research and essential components over the next few years.
It will upgrade the LHC by increasing the number of particle collisions by a factor of 10.
Supercomputers at STFC’s Hartree Centre are part of a massive global project to speed up the search to find the best existing anti-viral drugs that are most effective for treating for COVID-19 – and anyone with a personal computer can help!
Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.
Scientists are deploying this state-of-the-art X-ray crystallography facility to study biological molecules related to the COVID-19 pandemic.
The lab is responding to the coronavirus crisis by imaging disease-related biomolecules, developing standards for reliable coronavirus testing and enabling other essential research.
Health Canada has authorized Vexos Inc., a Canadian electronics manufacturing and custom materials solutions company, for the Mechanical Ventilator Milano (MVM) ventilator. This approval means that Vexos Inc. can manufacture and supply ventilators as part of a national, made-in-Canada, effort to treat patients most severely affected by the COVID-19 virus.
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization to the ventilator designed by an international collaboration of nuclear and particle physicists, the Mechanical Ventilator Milano (MVM). This is an important step in getting the MVM ventilator to patients around the world who are suffering the respiratory effects of the COVID-19 virus.
The Mechanical Ventilator Milano (MVM) design centres around the gas handling and control systems found in dark matter experiments combined with the 1961 Manley ventilator to produce a simple design. MVM uses readily available materials, eliminating supply chain limitations for more complex designs. It is open-source and can be accessed and modified by nations around the world in an effort to rapidly produce ventilators to address the immediate needs.
Face shields are part of the recommended PPE for healthcare workers who may be exposed to COVID-19 through the course of their work ... Not only can the headband be printed quickly, but its design aligns with the spacing of a three-hole punch, allowing for a multitude of materials to be used for the shield itself, even “something as simple as a clear plastic report cover”.
With personal protective equipment for frontline workers being an immediate concern, SNOLAB has taken an inventory of cleanroom personal protective equipment onsite and brought much of it up from underground earlier this week. The science team has been in contact with Health Sciences North (HSN) to determine where we can help meet the needs of local healthcare workers.
TRIUMF's work towards a low-cost, made-in-Canada ventilator for COVID-19 patients was the focus of a CBC segment that aired on Friday, August 28.
The objective of the Mechanical Ventilator Milano (MVM) collaboration is to design, develop, certify, and build an open-source ventilator that is safe, powerful, yet gentle, on the lungs. TRIUMF has contributed across the board to the Canadian effort, including testing, certification, and design of the control module and associated software. In a recent important step for the MVM collaboration, the United States Food and Drug Administration (FDA) recently granted Emergency Use Authorization for the MVM prototype in the United States.
In the face of the global COVID-19 pandemic, groups from across the TRIUMF community have mobilized to support a variety of health-focused initiatives.
While IceCube remains operational, its home research center at UW–Madison, the Wisconsin IceCube Particle Astrophysics Center, WIPAC, is temporarily providing some of its available computing resources to Folding@home. This citizen-science distributed-computing project crowdsources computationally intensive tasks like simulating protein dynamics. Distributed computing projects like Folding@home combine the power of thousands of individual computers contributed by their owners to process different portions of data simultaneously, significantly speeding up their results.